surmount 2 tirzepatide Lilly Shows Superiority in SURMOUNT-3 and 4 SURMOUNT-2: Tirzepatide Treatment Leads to

Martin Makary said the agency will, "take decisive steps to restrict GLP-1 active pharmaceutical ingredients (APIs) intended for use in non-FDA-approved compounded drugs that are being mass-marketed by companies including Hims & Hers and other compounding pharmacies as similar alternatives to FDA-approved drugs

Pierre-Louis: So theres been this big kind of tension brewing in recent months about the rise of what we might call imitation GLP-1s, like, the compounded versions

I wish that I had tracked my food intake, because I was really tired on 1.5 mg and I definitely wasn't eating enough food.

"You would do less invasive, less aggressive things first," says Dr